Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to TNF inhibitors: 52-week Results from a Phase 3 Study Genovese, M., Helliwell, P., Combe, B., Kremer, J., Adams, D., Lee, C., Kerr, L., Nash, P., Rahman, P. J RHEUMATOL PUBL CO. 2018: 996

View details for Web of Science ID 000438512300097